Granules India gets EU GMP certificate for Unit V facility in Andhra Pradesh

30 Jan 2025 Evaluate

Granules India has received EU GMP certificate for Active Pharmaceutical Ingredients (APIs) and Finished Dosages (FDs) for its Unit V facility located at Visakhapatnam, Andhra Pradesh. The EU (National Centre for Public Health and Pharmacy, Hungary) Authority conducted the audit of the facility in the month of November 2024. This facility manufactures APIs & formulations of oncology and non-oncology products.

Granules India is manufacturer and supplier of pharmaceutical products. Its products include active pharmaceutical ingredients like tablets, caplets, rapid release, pharmaceutical, formulation intermediates (PFI) and Finished Dosages.


Granules India Share Price

473.15 11.60 (2.51%)
03-Mar-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1585.15
Dr. Reddys Lab 1119.80
Cipla 1407.45
Lupin 1952.00
Zydus Lifesciences 870.70
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...